We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Spanish API Maker Ercros Warned for GMP, Validation Problems

Spanish API Maker Ercros Warned for GMP, Validation Problems

August 10, 2012

The FDA has warned Spanish industrial giant and active pharmaceutical ingredient (API) maker Ercros S.A. for GMP nonconformities, including various validation lapses and building disrepair that invites pests.

Ercros, a leading producer and exporter of fosfomycins for use in antibiotic drugs, was reprimanded in part because its response to a July 2011 inspection of its Aranjuez (Madrid), Spain, facility was inadequate, the recently posted warning letter states.

Concerns about the purity of the plant’s purified water system account for two of the letter’s six observations. Ercros failed to validate the performance of the water system, which provides water for API products used to make sterile drug products, FDA investigators say.

While the FDA has its own policies and focus areas for process validation, the EMA goes about it another way. If the EMA inspectors visited tomorrow, would you pass or fail?

With FDAnews’ newest webinar, Managing EMA Drug Process Validation Comparing and Contrasting the EMA and FDA’s Process Validation Guidelines, you and your entire office will be prepared.

With this webinar, you’ll get a side-by-side commented comparison of the 2012 EMA Process Validation Draft Guideline vs. the FDA 2011 Process Validation Final Guidance. This three-column worksheet shows the similarities and differences between FDA and EMA approaches at a glance.

The best news — you and your colleagues will participate from the comfort of your own office. No planes, no hotels, no precious time away from work and family — just 90 minutes of solid, interactive learning via the Web. Why wait, register today!

Upcoming Events

  • 09Aug

    Medical Device Premarket Review Pathways and FDA Mechanisms for Expedited Review

  • 10Aug

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

  • 08Sep

    Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 20Sep

    Building a World-Class Pharmaceutical Advertising and Promotion Review Program

  • 22Sep

    FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Bioventus’ neXus SonaStar Elite Gets 510(k) Clearance

  • Civica Launches Its First Lower-Cost Generic Drug

  • Pulse Biosciences’ CellFX Gets 510(k) Clearance for Expanded Energy Settings

  • Merck to Face MDL Regarding Gardasil HPV Vaccine Side Effects

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing